Literature DB >> 30842228

Comparable Serum and Plasma 1,3-β-d-Glucan Values Obtained Using the Wako β-Glucan Test in Patients with Probable or Proven Fungal Diseases.

Elena De Carolis1, Federica Marchionni1, Riccardo Torelli1, Patrizia Posteraro2, Gennaro De Pascale3,4, Simone Carelli3,4, Maurizio Sanguinetti5,6, Brunella Posteraro7,8.   

Abstract

Entities:  

Keywords:  beta-glucan; biomarker; individualized diagnosis

Mesh：

Substances：

Year:  2019        PMID： 30842228      PMCID： PMC6498008          DOI： 10.1128/JCM.00149-19

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  8 in total

Review 1.  Early diagnosis of invasive mould infections and disease.

Authors:  Frédéric Lamoth; Thierry Calandra
Journal:  J Antimicrob Chemother       Date:  2017-03-01       Impact factor: 5.790

2.  β-D-glucan testing is important for diagnosis of invasive fungal infections.

Authors:  Elitza S Theel; Christopher D Doern
Journal:  J Clin Microbiol       Date:  2013-07-12       Impact factor: 5.948

3.  Clinical viability of Fungitell, a new (1→3)-β-D: -glucan measurement kit, for diagnosis of invasive fungal infection, and comparison with other kits available in Japan.

Authors:  Koichiro Yoshida; Hisashi Shoji; Takahiro Takuma; Yoshihito Niki
Journal:  J Infect Chemother       Date:  2011-01-06       Impact factor: 2.211

Review 4.  New molecular and surrogate biomarker-based tests in the diagnosis of bacterial and fungal infection in febrile neutropenic patients.

Authors:  Sharon C-A Chen; Dimitrios P Kontoyiannis
Journal:  Curr Opin Infect Dis       Date:  2010-12       Impact factor: 4.915

Review 5.  A systematic review and meta-analysis of diagnostic accuracy of serum 1,3-β-D-glucan for invasive fungal infection: Focus on cutoff levels.

Authors:  Song He; Ju-Ping Hang; Ling Zhang; Fang Wang; De-Chun Zhang; Fang-Hong Gong
Journal:  J Microbiol Immunol Infect       Date:  2014-07-28       Impact factor: 4.399

6.  Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.

Authors:  Ben De Pauw; Thomas J Walsh; J Peter Donnelly; David A Stevens; John E Edwards; Thierry Calandra; Peter G Pappas; Johan Maertens; Olivier Lortholary; Carol A Kauffman; David W Denning; Thomas F Patterson; Georg Maschmeyer; Jacques Bille; William E Dismukes; Raoul Herbrecht; William W Hope; Christopher C Kibbler; Bart Jan Kullberg; Kieren A Marr; Patricia Muñoz; Frank C Odds; John R Perfect; Angela Restrepo; Markus Ruhnke; Brahm H Segal; Jack D Sobel; Tania C Sorrell; Claudio Viscoli; John R Wingard; Theoklis Zaoutis; John E Bennett
Journal:  Clin Infect Dis       Date:  2008-06-15       Impact factor: 9.079

7.  Comparative Analysis of the Wako β-Glucan Test and the Fungitell Assay for Diagnosis of Candidemia and Pneumocystis jirovecii Pneumonia.

Authors:  Ricarda Friedrich; Elfriede Rappold; Christian Bogdan; Jürgen Held
Journal:  J Clin Microbiol       Date:  2018-08-27       Impact factor: 5.948

Review 8.  Translational Development and Application of (1→3)-β-d-Glucan for Diagnosis and Therapeutic Monitoring of Invasive Mycoses.

Authors:  Matthew W McCarthy; Ruta Petraitiene; Thomas J Walsh
Journal:  Int J Mol Sci       Date:  2017-05-24       Impact factor: 5.923
  8 in total
  2 in total

Review 1.  Updates in Laboratory Diagnostics for Invasive Fungal Infections.

Authors:  David Terrero-Salcedo; Margaret V Powers-Fletcher
Journal:  J Clin Microbiol       Date:  2020-05-26       Impact factor: 5.948

2.  Comparative performance evaluation of Wako β-glucan test and Fungitell assay for the diagnosis of invasive fungal diseases.

Authors:  Elena De Carolis; Federica Marchionni; Riccardo Torelli; Morandotti Grazia Angela; Livio Pagano; Rita Murri; Gennaro De Pascale; Giulia De Angelis; Maurizio Sanguinetti; Brunella Posteraro
Journal:  PLoS One       Date:  2020-07-29       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.